Metraipolis › archive › dc_b199d95c857d
Real-World Safety Profile of Adjuvant Abemaciclib in HR+/HER2- Early Breast Cancer — Europe PMC PMID:42649858
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42649858
- DOI
- 10.3390/cancers18162543
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-16T23:53:17.171Z
- SHA-256 of the archived text
473b24a32c474a66de743148a221bf0aa7cbbcb3e3dcd37a29109bfb11c40f37- Stable URL of this page
https://metraipolis.com/documento/dc_b199d95c857d
How to cite
Real-World Safety Profile of Adjuvant Abemaciclib in HR+/HER2- Early Breast Cancer — Europe PMC PMID:42649858 — Europe PMC (en), https://europepmc.org/article/MED/42649858 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b199d95c857d (Metraipolis archive dc_b199d95c857d, sha256 473b24a32c474a66de743148a221bf0aa7cbbcb3e3dcd37a29109bfb11c40f37)
BibTeX
@misc{dcb199d95c857d,
title = {Real-World Safety Profile of Adjuvant Abemaciclib in HR+/HER2- Early Breast Cancer — Europe PMC PMID:42649858},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42649858},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b199d95c857d; sha256 473b24a32c474a66de743148a221bf0aa7cbbcb3e3dcd37a29109bfb11c40f37},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42649858. Agents can read the archived copy with the MCP tool read_document.